A detailed history of Legal & General Group PLC transactions in Abbott Laboratories stock. As of the latest transaction made, Legal & General Group PLC holds 14,258,807 shares of ABT stock, worth $1.62 Billion. This represents 0.35% of its overall portfolio holdings.

Number of Shares
14,258,807
Previous 14,258,807 -0.0%
Holding current value
$1.62 Billion
Previous $1.63 Billion -0.0%
% of portfolio
0.35%
Previous 0.35%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$100.07 - $118.13 $8.87 Million - $10.5 Million
-88,645 Reduced 0.62%
14,258,807 $1.63 Billion
Q2 2024

Aug 14, 2024

BUY
$100.73 - $112.44 $1.06 Million - $1.18 Million
10,506 Added 0.07%
14,347,452 $1.49 Billion
Q1 2024

Jul 01, 2024

BUY
$109.52 - $120.96 $14.4 Million - $15.9 Million
131,555 Added 0.93%
14,336,946 $1.63 Billion
Q1 2024

May 14, 2024

SELL
$109.52 - $120.96 $10.3 Million - $11.4 Million
-93,859 Reduced 0.66%
14,205,391 $1.61 Billion
Q4 2023

Feb 15, 2024

BUY
$90.19 - $110.4 $169 Million - $207 Million
1,873,411 Added 15.08%
14,299,250 $1.57 Billion
Q3 2023

Nov 14, 2023

SELL
$95.53 - $114.62 $38.9 Million - $46.7 Million
-407,288 Reduced 3.17%
12,425,839 $1.2 Billion
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $51.2 Million - $57.1 Million
508,439 Added 4.13%
12,833,127 $1.4 Billion
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $4.35 Million - $5.12 Million
44,918 Added 0.37%
12,324,688 $1.25 Billion
Q4 2022

Feb 14, 2023

SELL
$95.06 - $111.52 $58.2 Million - $68.3 Million
-612,544 Reduced 4.75%
12,279,770 $1.35 Billion
Q3 2022

Nov 14, 2022

SELL
$96.76 - $112.03 $34.8 Million - $40.3 Million
-360,116 Reduced 2.72%
12,892,314 $1.25 Billion
Q2 2022

Aug 22, 2022

BUY
$102.07 - $123.37 $57.7 Million - $69.8 Million
565,475 Added 4.46%
13,252,430 $1.44 Billion
Q1 2022

May 16, 2022

BUY
$114.02 - $139.04 $86.9 Million - $106 Million
761,956 Added 6.39%
12,686,955 $1.5 Billion
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $45.1 Million - $55.2 Million
-389,988 Reduced 3.17%
11,924,999 $1.68 Billion
Q3 2021

Nov 15, 2021

BUY
$116.66 - $129.06 $51.8 Million - $57.3 Million
443,776 Added 3.74%
12,314,987 $1.45 Billion
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $66.8 Million - $78.6 Million
631,380 Added 5.62%
11,871,211 $1.38 Billion
Q1 2021

May 17, 2021

SELL
$108.84 - $128.23 $12.5 Million - $14.7 Million
-114,771 Reduced 1.01%
11,239,831 $1.35 Billion
Q4 2020

Feb 12, 2021

SELL
$105.0 - $114.42 $1.13 Million - $1.23 Million
-10,746 Reduced 0.09%
11,354,602 $1.24 Billion
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $12.4 Million - $15.1 Million
135,441 Added 1.21%
11,365,348 $1.24 Billion
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $10.1 Million - $12.9 Million
131,920 Added 1.19%
11,229,907 $1.03 Billion
Q1 2020

May 14, 2020

BUY
$62.82 - $91.86 $24.1 Million - $35.3 Million
384,420 Added 3.59%
11,097,987 $876 Million
Q4 2019

Feb 13, 2020

BUY
$78.51 - $87.4 $7.74 Million - $8.61 Million
98,562 Added 0.93%
10,713,567 $931 Million
Q3 2019

Nov 13, 2019

BUY
$81.84 - $88.74 $14.3 Million - $15.5 Million
174,158 Added 1.67%
10,615,005 $888 Million
Q2 2019

Aug 14, 2019

SELL
$72.88 - $85.0 $43,436 - $50,660
-596 Reduced 0.01%
10,440,847 $878 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $139 Million - $168 Million
2,098,441 Added 25.15%
10,441,443 $835 Million
Q4 2018

Feb 15, 2019

BUY
$65.56 - $74.27 $44.1 Million - $49.9 Million
672,358 Added 8.77%
8,343,002 $603 Million
Q3 2018

Nov 20, 2018

BUY
$60.81 - $73.36 $7.38 Million - $8.91 Million
121,421 Added 1.61%
7,670,644 $563 Million
Q2 2018

Aug 10, 2018

SELL
$57.57 - $63.54 $20.2 Million - $22.2 Million
-350,061 Reduced 4.43%
7,549,223 $460 Million
Q1 2018

May 17, 2018

SELL
$56.27 - $63.62 $37.8 Million - $42.8 Million
-672,382 Reduced 7.84%
7,899,284 $473 Million
Q4 2017

Feb 13, 2018

BUY
$53.68 - $57.47 $460 Million - $493 Million
8,571,666
8,571,666 $489 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $198B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.